Home › Funds › SILVERARC CAPITAL MANAGEMENT, LLC › ACRS

SILVERARC CAPITAL MANAGEMENT, LLC position in ACRS

ACLARIS THERAPEUTICS INC · Health Care

SILVERARC CAPITAL MANAGEMENT, LLC reported holding 1,946,482 shares of ACRS (ACLARIS THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$10.3M, representing 1.20% of its reported portfolio and ranking #28 among its reported holdings. SILVERARC CAPITAL MANAGEMENT, LLC has disclosed ACRS holdings in 2 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.95M sh
Reported value held$10.30M
Portfolio Weight1.20%
First reportedQ3 2023
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SILVERARC CAPITAL MANAGEMENT, LLC's ACRS position evolved

SILVERARC CAPITAL MANAGEMENT, LLC first disclosed a stake in ACRS in Q3 2023 at 2,400 shares (US$16K). The position peaked in Q2 2026 at 1,946,482 shares, worth US$10.3M. Across 2 filings, SILVERARC CAPITAL MANAGEMENT, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 1,946,482 shares valued at US$10.3M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.40K $16.44K New
Q2 2026 1.95M $10.30M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ACRS and 13F data

ACRS (ACLARIS THERAPEUTICS INC) is a Health Care company. 43 other funds we track also report a position in ACRS — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$67.3M), BML Capital Management, LLC (US$63.3M), Deep Track Capital, LP (US$49.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ACRS

All ACRS fund holders →

FAQ

How long has SILVERARC CAPITAL MANAGEMENT, LLC held ACRS?

SILVERARC CAPITAL MANAGEMENT, LLC has disclosed ACRS holdings in 2 of the last 12 reported quarters, going back to Q3 2023.

What is SILVERARC CAPITAL MANAGEMENT, LLC's current position in ACRS?

As of Q2 2026, SILVERARC CAPITAL MANAGEMENT, LLC holds 1.95M shares of ACRS (ACLARIS THERAPEUTICS INC), valued at $10.30M, representing 1.20% of its reported portfolio and ranking #28.

Has SILVERARC CAPITAL MANAGEMENT, LLC been buying or selling ACRS?

In the latest 13F filing (Q2 2026), SILVERARC CAPITAL MANAGEMENT, LLC newly opened its position in ACRS. The position peaked in Q2 2026 at 1.95M shares.

Which other funds hold ACRS?

Other major institutional holders of ACRS include RA CAPITAL MANAGEMENT, L.P., BML Capital Management, LLC, Deep Track Capital, LP, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.